Studies have demonstrated a strong relationship between physical inactivity and the presence of cardiovascular risk factors such as hypertension, insulin resistance, diabetes, dyslipidemia, obesity, and metabolic syndrome. On the other hand, regular physical exercise has been recommended to prevent and treat cardiovascular diseases, their risk factors, and other chronic conditions. Systemic vibration therapy (SVT) has been proposed as an alternative exercise modality for this population. This project aimed to assess clinical, metabolic, physical, functional, biochemical parameters, quality of life, and sleep quality in individuals with metabolic syndrome undergoing whole-body vibration exercises on a vibratory platform. This study aimed to evaluate clinical, metabolic, physical-functional, biochemical parameters, quality of life, and sleep quality in individuals with MSy undergoing whole-body vibration exercises. Assessments were conducted before and after the intervention and included cardiovascular responses, dyspnea, fatigue, anthropometric measurements (neck, abdominal, hip, arm, and ankle circumferences), body composition, anterior trunk and lumbar spine flexibility, and laboratory analyses (complete blood count, cholesterol profile, triglycerides, creatinine, uric acid, cortisol, glucose, insulin, growth hormone, vitamin D, and other biomarkers). Questionnaires assessed quality of life and sleep. Neuromuscular function, handgrip strength, lower limb isometric dynamometry, joint goniometry, and functional tests were evaluated. Participants were randomized into two SVT protocol groups: Fixed Frequency (FF) and Variable Frequency (VF). Both protocols were conducted on a vibratory platform with alternating base displacement. In the FF group, a frequency of 5 Hz was applied, with peak-to-peak displacements of 2.5, 5.0, and 7.5 mm, a work time of 1 minute (10s "on" and 50s "off"), and 1 minute of rest in an upright position. In the VF group, frequencies varied from 5 to 16 Hz (increasing by 1 Hz per session), with a work time of 1 minute and 1 minute of rest, while peak-to-peak displacements remained the same as in the FF protocol. The protocols were performed in static and dynamic squat positions, twice a week, over six weeks, totaling 12 sessions. It is expected that this vibratory platform intervention can improve clinical, physical, biochemical, and functional parameters, as well as quality of life and sleep quality in individuals with MSy.
Age range
45 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Glycated Hemoglobin (HbA1c)
Timeframe: From enrollment to the end of treatment at 6 weeks.
Lipid Profile and Fasting Blood Glucose
Timeframe: From enrollment to the end of treatment at 6 weeks.
Uric Acid Levels
Timeframe: From enrollment to the end of treatment at 6 weeks.
Hormonal Biomarkers
Timeframe: From enrollment to the end of treatment at 6 weeks.
Metabolic Biomarkers
Timeframe: From enrollment to the end of treatment at 6 weeks.
Total Body Water
Timeframe: From enrollment to the end of treatment at 6 weeks.
Lean Body Mass, Fat Mass, and Skeletal Muscle Mass
Timeframe: From enrollment to the end of treatment at 6 weeks.
Body Fat Percentage
Timeframe: From enrollment to the end of treatment at 6 weeks.
Visceral Fat Area
Timeframe: From enrollment to the end of treatment at 6 weeks.
Basal Metabolic Rate
Timeframe: From enrollment to the end of treatment at 6 weeks.
Body Mass Index (BMI)
Timeframe: From enrollment to the end of treatment at 6 weeks.
Waist-to-Hip Ratio (WHR)
Timeframe: From enrollment to the end of treatment at 6 weeks.
Waist-to-Height Ratio (WHtR)
Timeframe: From enrollment to the end of treatment at 6 weeks.
Conicity Index
Timeframe: From enrollment to the end of treatment at 6 weeks.
Anthropometric measures
Timeframe: From enrollment to the end of treatment at 6 weeks.